CryoPort Inc (CYRX) Q4 2025 Earnings Call Highlights: Record Growth in Cell and Gene Therapy Revenue [Yahoo! Finance]
CryoPort, Inc. (CYRX)
NASDAQ:AMEX Investor Relations:
ir.cryoport.com
Company Research
Source: Yahoo! Finance
Full-Year Revenue from Continuing Operations: $176.2 million, exceeding prior guidance. Fourth Quarter Commercial Cell and Gene Therapy Revenue: Increased 29% year over year to $33.4 million. Clinical Trial Revenue: Grew 14% year over year to $47.1 million. Gross Margin: 47% for 2025. Adjusted EBITDA Improvement: $12 million year-over-year improvement. Life Sciences Services Revenue Growth: Increased 18% year over year, with BioStorage and BioServices revenue growing 22%. Life Sciences Product Segment Revenue Growth: 7% year over year in 2025. Full-Year 2026 Revenue Guidance: $190 million to $194 million. Warning! GuruFocus has detected 6 Warning Signs with CYRX. Is CYRX fairly valued? Test your thesis with our free DCF calculator. Release Date: March 03, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points CryoPort Inc ( NASDAQ:CYRX ) reported full-year revenue from continuing operations of
Show less
Read more
Impact Snapshot
Event Time:
CYRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYRX alerts
High impacting CryoPort, Inc. news events
Weekly update
A roundup of the hottest topics
CYRX
News
- CryoPort (CYRX) had its price target raised by Needham & Company LLC from $12.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- CryoPort Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Cryoport (CYRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial ResultsPR Newswire
CYRX
Earnings
- 3/3/26 - Miss
CYRX
Sec Filings
- 3/5/26 - Form 10-K
- 3/3/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- CYRX's page on the SEC website